InvestorsHub Logo
Followers 44
Posts 4244
Boards Moderated 0
Alias Born 09/01/2017

Re: ae kusterer post# 524167

Sunday, 10/23/2022 4:50:47 PM

Sunday, October 23, 2022 4:50:47 PM

Post# of 693990
The title implies that the combination treatments of DCVax with the interleukin and PD1/PDL1 (keytruda) adjuvant, and the anecdotal comments regarding higher percentages of OS extended observations.

DCVax is the common component of the combo treatments and appears to play an SOC role in the combo research and trials!

Imo the odds are the presentation enhances the DCVax case.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News